Lamassu Pharma LLC

Durham, NC

UEI
RB6PG7UNAKE3
CAGE
8CVY4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
205 Regiment Way, Durham, NC 27705, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a novel lipase inhibitor for the treatment of acute pancreatitis R44DK125219 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $4,340,363

Quick answers

Is Lamassu Pharma LLC registered in SAM.gov?

Yes. Lamassu Pharma LLC's SAM.gov registration is active through April 3, 2027.

What is Lamassu Pharma LLC's most recent federal award?

Lamassu Pharma LLC's most recent federal grant award is Development of a novel lipase inhibitor for the treatment of acute pancreatitis (R44DK125219), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on July 7, 2020.

On GovTribe

See Lamassu Pharma LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login